These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 12929872)

  • 1. Cost-effectiveness of treatment of chronic hepatitis B with interferon-alpha.
    Babu S
    Natl Med J India; 2003; 16(3):175; author reply 175-6. PubMed ID: 12929872
    [No Abstract]   [Full Text] [Related]  

  • 2. Cost-effectiveness of treatment of chronic hepatitis B with interferon-alpha.
    Desai HG
    Natl Med J India; 2003; 16(3):175; author reply 175-6. PubMed ID: 12929870
    [No Abstract]   [Full Text] [Related]  

  • 3. Cost-effectiveness of treatment of chronic hepatitis B with interferon-alpha.
    Nagral A
    Natl Med J India; 2003; 16(3):175; author reply 175-6. PubMed ID: 12929871
    [No Abstract]   [Full Text] [Related]  

  • 4. Treatment of chronic hepatitis B with interferon-alpha: cost-effectiveness in developing countries.
    Aggarwal R; Ghoshal UC; Naik SR
    Natl Med J India; 2002; 15(6):320-7. PubMed ID: 12540064
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of chronic hepatitis B in india: what is the cost of life?
    Anand AC
    Natl Med J India; 2002; 15(6):317-9. PubMed ID: 12540063
    [No Abstract]   [Full Text] [Related]  

  • 6. [Cost-effectiveness analysis of the treatment of chronic hepatitis C].
    Joliot E; Vanlemmens C; Kerleau M; Le Gales C; Woronoff-Lemsi MC; Flori YA; Seror V; Hrusovsky S; Monnet E; Bresson-Hadni S; Miguet JP
    Gastroenterol Clin Biol; 1996; 20(11):958-67. PubMed ID: 9119185
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Treatment of chronic hepatitis B].
    Dybowska D; Pilarczyk M
    Przegl Epidemiol; 2004; 58 Suppl 1():139-43. PubMed ID: 15807174
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The cost effectiveness of alpha interferon in the treatment of chronic active hepatitis C.
    Shiell A; Briggs A; Farrell GC
    Med J Aust; 1994 Mar; 160(5):268-72. PubMed ID: 8107627
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatitis C therapy: is it really worth it?
    Johanson JF
    Am J Gastroenterol; 1999 May; 94(5):1412-3. PubMed ID: 10235231
    [No Abstract]   [Full Text] [Related]  

  • 10. Cost effectiveness of interferon in chronic active hepatitis C.
    Turnbull C; Sugano D
    Med J Aust; 1994 Jul; 161(2):169; author reply 170. PubMed ID: 8028544
    [No Abstract]   [Full Text] [Related]  

  • 11. The cost-effectiveness of alternative therapeutic strategies for the management of chronic hepatitis B in Poland.
    Orlewska E
    Value Health; 2002; 5(5):405-21. PubMed ID: 12201858
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost-effectiveness analysis of interferon-alpha therapy in the treatment of chronic hepatitis B in Taiwan.
    Pwu RF; Chan KA
    J Formos Med Assoc; 2002 Sep; 101(9):632-41. PubMed ID: 12645191
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Medico-economic assessment of the therapeutic management of patients with hepatitis C].
    Loubière S; Rotily M; Moatti JP
    Gastroenterol Clin Biol; 2000 Nov; 24(11):1047-51. PubMed ID: 11139674
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Applicability of cost-effectiveness analysis to management of chronic hepatitis B.
    Dan YY; Lim SG
    J Gastroenterol Hepatol; 2007 Sep; 22(9):1357-9. PubMed ID: 17716341
    [No Abstract]   [Full Text] [Related]  

  • 15. [Treatment of chronic viral hepatitis].
    Pedersen C; Pedersen CR
    Ugeskr Laeger; 2008 Jun; 170(24):2137-40. PubMed ID: 18565297
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Productivity improvements in hepatitis C treatment: impact on efficacy, cost, cost-effectiveness and quality of life.
    Lidgren M; Hollander A; Weiland O; Jönsson B
    Scand J Gastroenterol; 2007 Jul; 42(7):867-77. PubMed ID: 17558912
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interferon-alfa in the treatment of chronic hepatitis B.
    Zhang FK
    Hepatobiliary Pancreat Dis Int; 2004 Aug; 3(3):337-40. PubMed ID: 15313664
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of chronic hepatitis B.
    Moreno Otero R
    Rev Esp Enferm Dig; 2000 Sep; 92(9):555-60. PubMed ID: 11138237
    [No Abstract]   [Full Text] [Related]  

  • 19. Economics of chronic hepatitis B and hepatitis C.
    Rajendra A; Wong JB
    J Hepatol; 2007 Oct; 47(4):608-17. PubMed ID: 17697724
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Future perspectives and strategies in managing resistance to analogue antiviral drugs in the treatment of chronic hepatitis B].
    Bourlière M
    Gastroenterol Clin Biol; 2006 Oct; 30(10 Pt 2):3S34-6. PubMed ID: 17075495
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.